BiOasis to present at 10th Annual Brains for Brain Workshop
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 09, 2016 04:47PM
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 21, 2018 10:31AM
|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 18, 2019 04:05PM
|
Re: American Diabetes Association Meeting, June 7-11, 2019
|
2
|
Resverlogix Corp.
|
Jun 10, 2019 04:46PM
|
Re: AEGIS-II trial
|
2
|
Resverlogix Corp.
|
Mar 22, 2018 01:06PM
|
Re: Bear
|
2
|
Zenith Epigenetics
|
Apr 16, 2018 01:24PM
|
Re: ... my letter forwarded to IR...
|
2
|
Resverlogix Corp.
|
Jan 10, 2017 10:24AM
|
Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone
|
2
|
Resverlogix Corp.
|
May 30, 2017 12:31PM
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
2
|
Resverlogix Corp.
|
Jun 14, 2019 03:00PM
|
Re: The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice
|
2
|
Resverlogix Corp.
|
Sep 29, 2017 01:14PM
|
Re: Keystone Symposia...
|
2
|
Resverlogix Corp.
|
Jan 26, 2017 09:38AM
|
Re: biOasis CEO Dr. Mark Day Releases Details of Corporate Plans in Message to Shareholders
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 14, 2017 10:36AM
|
Re: Primate/Monkey Studies / Financing
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 07, 2019 12:03PM
|
June 30-July 02, 2016: 9th World Drug Delivery Summit
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 28, 2016 10:39AM
|
Re: 9 consecutive trading days
|
2
|
Resverlogix Corp.
|
May 23, 2018 04:04PM
|
Re: Endocyte Valuation
|
2
|
Zenith Epigenetics
|
Oct 18, 2018 02:35PM
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Mar 30, 2020 09:30AM
|
Updates from Mark Day
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 29, 2018 04:40PM
|
Bioasis Appoints Dr. Deborah Rathjen as President & Chief Executive Officer
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 13, 2019 09:28AM
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
2
|
Resverlogix Corp.
|
Dec 02, 2019 01:17PM
|